258 related articles for article (PubMed ID: 25731647)
1. Immunohistochemical study of MUC1, MUC2 and MUC5AC in colorectal carcinoma and review of literature.
Kesari MV; Gaopande VL; Joshi AR; Babanagare SV; Gogate BP; Khadilkar AV
Indian J Gastroenterol; 2015 Jan; 34(1):63-7. PubMed ID: 25731647
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.
Terada T
Int J Clin Exp Pathol; 2013; 6(4):613-21. PubMed ID: 23573307
[TBL] [Abstract][Full Text] [Related]
3. Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact.
Park SY; Roh SJ; Kim YN; Kim SZ; Park HS; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Oncol Rep; 2009 Sep; 22(3):649-57. PubMed ID: 19639217
[TBL] [Abstract][Full Text] [Related]
4. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.
Betge J; Schneider NI; Harbaum L; Pollheimer MJ; Lindtner RA; Kornprat P; Ebert MP; Langner C
Virchows Arch; 2016 Sep; 469(3):255-65. PubMed ID: 27298226
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of mucins (MUC1, MUC2 and MUC5AC) expression profile in endoscopic ultrasound-guided fine-needle aspiration specimens of the pancreas.
Wang Y; Gao J; Li Z; Jin Z; Gong Y; Man X
Int J Cancer; 2007 Dec; 121(12):2716-22. PubMed ID: 17708554
[TBL] [Abstract][Full Text] [Related]
6. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
7. Differential mucin phenotypes and their significance in a variation of colorectal carcinoma.
Imai Y; Yamagishi H; Fukuda K; Ono Y; Inoue T; Ueda Y
World J Gastroenterol; 2013 Jul; 19(25):3957-68. PubMed ID: 23840140
[TBL] [Abstract][Full Text] [Related]
8. Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.
Walsh MD; Clendenning M; Williamson E; Pearson SA; Walters RJ; Nagler B; Packenas D; Win AK; Hopper JL; Jenkins MA; Haydon AM; Rosty C; English DR; Giles GG; McGuckin MA; Young JP; Buchanan DD
Mod Pathol; 2013 Dec; 26(12):1642-56. PubMed ID: 23807779
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of MUC1, MUC2 and MUC5AC expressions in gastric carcinoma.
İlhan Ö; Han Ü; Önal B; Çelık SY
Turk J Gastroenterol; 2010 Dec; 21(4):345-52. PubMed ID: 21331986
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of mucin 1 and mucin 2 in colorectal cancer.
Kasprzak A; Siodła E; Andrzejewska M; Szmeja J; Seraszek-Jaros A; Cofta S; Szaflarski W
World J Gastroenterol; 2018 Sep; 24(36):4164-4177. PubMed ID: 30271081
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of MUC1, MUC2, and MUC5AC in carcinomas of various sites: an immunohistochemical study.
Lau SK; Weiss LM; Chu PG
Am J Clin Pathol; 2004 Jul; 122(1):61-9. PubMed ID: 15272531
[TBL] [Abstract][Full Text] [Related]
12. Expression of mucins and E-cadherin in gastric carcinoma and their clinical significance.
Zhang HK; Zhang QM; Zhao TH; Li YY; Yi YF
World J Gastroenterol; 2004 Oct; 10(20):3044-7. PubMed ID: 15378790
[TBL] [Abstract][Full Text] [Related]
13. Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma.
Matsukita S; Nomoto M; Kitajima S; Tanaka S; Goto M; Irimura T; Kim YS; Sato E; Yonezawa S
Histopathology; 2003 Jan; 42(1):26-36. PubMed ID: 12493022
[TBL] [Abstract][Full Text] [Related]
14. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression.
Reis CA; David L; Correa P; Carneiro F; de Bolós C; Garcia E; Mandel U; Clausen H; Sobrinho-Simões M
Cancer Res; 1999 Mar; 59(5):1003-7. PubMed ID: 10070955
[TBL] [Abstract][Full Text] [Related]
15. MUC1, MUC2 and MUC5AC expressions in cardiac myxoma.
Chu PH; Jung SM; Yeh TS; Lin HC; Chu JJ
Virchows Arch; 2005 Jan; 446(1):52-5. PubMed ID: 15568157
[TBL] [Abstract][Full Text] [Related]
16. Immunoreactivity of Lewis blood group and mucin peptide core antigens: correlations with grade of dysplasia and malignant transformation in the colorectal adenoma-carcinoma sequence.
Baldus SE; Hanisch FG; Pütz C; Flucke U; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP
Histol Histopathol; 2002 Jan; 17(1):191-8. PubMed ID: 11813869
[TBL] [Abstract][Full Text] [Related]
17. Mucins MUC1, MUC2, MUC5AC and MUC6 expression in the evaluation of differentiation and clinico-biological behaviour of gastric carcinoma.
Pinto-de-Sousa J; David L; Reis CA; Gomes R; Silva L; Pimenta A
Virchows Arch; 2002 Mar; 440(3):304-10. PubMed ID: 11889602
[TBL] [Abstract][Full Text] [Related]
18. Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?
Molaei M; Mansoori BK; Mashayekhi R; Vahedi M; Pourhoseingholi MA; Fatemi SR; Zali MR
BMC Cancer; 2010 Oct; 10():537. PubMed ID: 20929551
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma.
Matsuda K; Masaki T; Watanabe T; Kitayama J; Nagawa H; Muto T; Ajioka Y
Jpn J Clin Oncol; 2000 Feb; 30(2):89-94. PubMed ID: 10768872
[TBL] [Abstract][Full Text] [Related]
20. MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6.
Pinto-de-Sousa J; Reis CA; David L; Pimenta A; Cardoso-de-Oliveira M
Virchows Arch; 2004 Mar; 444(3):224-30. PubMed ID: 14758553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
